Can Serum Drops Containing Doxycycline Provide a Supplemental Anti-Bacterial Effect in the Treatment of Bacterial Keratitis?

Purpose: Systemic doxycycline has been prescribed to reduce inflammation and enhance corneal healing in bacterial keratitis. Topical autologous serum drops (ASD) containing doxycycline following oral supplementation may additionally confer an anti-bacterial effect. The potential of this supplementat...

Full description

Saved in:
Bibliographic Details
Main Authors: David Mora-Boellstorff (Author), Kanwal Matharu (Author), Vishal Jhanji (Author), Regis P. Kowalski (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7d3fdce2acd34d4d96da7e25dfb004dc
042 |a dc 
100 1 0 |a David Mora-Boellstorff  |e author 
700 1 0 |a Kanwal Matharu  |e author 
700 1 0 |a Vishal Jhanji  |e author 
700 1 0 |a Regis P. Kowalski  |e author 
245 0 0 |a Can Serum Drops Containing Doxycycline Provide a Supplemental Anti-Bacterial Effect in the Treatment of Bacterial Keratitis? 
260 |b MDPI AG,   |c 2023-07-01T00:00:00Z. 
500 |a 10.3390/antibiotics12071145 
500 |a 2079-6382 
520 |a Purpose: Systemic doxycycline has been prescribed to reduce inflammation and enhance corneal healing in bacterial keratitis. Topical autologous serum drops (ASD) containing doxycycline following oral supplementation may additionally confer an anti-bacterial effect. The potential of this supplementation was evaluated by determining the in vitro susceptibility of bacterial keratitis isolates to doxycycline. Methods: The minimum inhibitory concentrations (MICs) of doxycycline against 100 bacterial keratitis isolates were determined using Etests. Twenty-seven <i>Staphylococcus aureus</i>, ten coagulase-negative <i>Staphylococci</i>, six <i>Streptococcus pneumoniae</i>, seven viridans group streptococci, seven other Gram-positive bacteria, nineteen <i>Pseudomonas aeruginosa</i>, eight <i>Serratia marcescens</i>, four <i>Moraxella</i> spp., two <i>Haemophilus</i> spp., and ten other Gram-negative bacteria isolates were tested. MICs of doxycycline were compared to a serum standard concentration of doxycycline (SSCD) of 4 µg/mL and concentrations that would be found in 50% and 20% serum component clinical preparations of ASD, corresponding to 50% SSCD (2 µg/mL) and 20% SSCD (0.8 µg/mL), respectively. MICs equal to or less than these values were used to deem a bacterial isolate susceptible. Results: For Gram-positive bacteria, susceptibilities to SSCD, 50% SSCD, and 20% SSCD were 86%, 65%, and 60%, respectively. For Gram-negative bacteria, susceptibilities to SSCD, 50% SSCD, and 20% SSCD were 37.2%, 23.3%, and 11.6%, respectively. Chi-squared analyses comparing Gram-positive and Gram-negative susceptibilities showed significantly greater susceptibility of Gram-positive bacteria at all three tested MICs (<0.0001, <0.0001, <0.0001). Conclusions: Our data suggest that autologous serum drops containing theoretic concentrations of doxycycline may provide an additional anti-bacterial effect in the treatment of bacterial keratitis, especially for Gram-positive bacterial keratitis compared to Gram-negative bacterial keratitis. 
546 |a EN 
690 |a doxycycline 
690 |a bacterial keratitis 
690 |a autologous serum drops 
690 |a susceptibility 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 7, p 1145 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/7/1145 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/7d3fdce2acd34d4d96da7e25dfb004dc  |z Connect to this object online.